A Cross-Sectional, Clinico-Epidemiological, Multicentre Study to Determine the Prevalence of Non-Alcoholic Fatty Liver Disease and Thyroid Dysfunction in Patients with Metabolic Syndrome, visiting the Endocrinology and Gastroenterology Out Patient Departments of Tertiary Health Care Centers in India.

Abbott India Limited0 个研究点目标入组 400 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Male and female patients, aged 18 to 65 years inclusive
•2.Patients with an established diagnosis of MetS as per the ATP III criteria and visiting the clinic as a part of their schedule

•1.Patients with history of drug intake likely to cause NAFLD (e.g. aspirin, amiodarone, corticosteroids, methotrexate, 5-fluorouracil, tamoxifen, valproate, zidovudine, didanosine, diltiazem) or TD (e.g. interferon, molecular-targeted agents, amiodarone, thyroid hormone, anti-thyroid drugs, lithium, iodine, dopamine)
•2.Patients with history of jejuno-ileal bypass or biliopancreatic diversion or extensive small bowel resection or total parenteral nutrition.
•3.Evidence of other forms of chronic liver disease, suspected or confirmed hepatocellular carcinoma, known HIV positive
•4.Female patients who are pregnant

发起方